Who
Tess Burleson
Director
Company insider
Files Form 4 as: Director, Decoy Therapeutics.
In numbers
- Trades disclosed
- 11
- Buys
- 2
- Sells
- 0
- Bought
- $9,989
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 10 Sep 2019
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 31 Aug 2026filed 2 Sep 2026 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 20 Feb 2024filed 22 Feb 2024 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,500 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —1,440 at $0.00 | filing |
| 7 Jun 2022filed 8 Jun 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $4,98627,700 at $0.18 | filing |
| 20 Jan 2022filed 21 Jan 2022 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 2 Dec 2020filed 4 Dec 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 23 Mar 2020filed 25 Mar 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 11 Feb 2020filed 13 Feb 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | $444,350 at $0.01 | filing |
| 11 Feb 2020filed 12 Feb 2020 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,0034,350 at $1.15 | filing |
| 10 Sep 2019filed 13 Sep 2019 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.